Thinking of joining a study?

Register your interest

NCT06711952 | RECRUITING | Alzheimer Disease


German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)
Sponsor:

Ludwig Maximilians - University of Munich

Information provided by (Responsible Party):

Robert Perneczky

Brief Summary:

The SCD-Q (Subjective Cognitive Decline-Questionnaire) is an established instrument to quantify self-perceived cognitive decline. Both self- and informant-rated versions of the SCD-Q are available. However, the SCD-Q has not been validated in the German language yet. Hence, the investigators aim to validate the self-reported SCD-Q in a clinical sample in Germany.

Condition or disease

Alzheimer Disease

Subjective Cognitive Decline

Intervention/treatment

Subjective Cognitive Decline-Questionnaire (SCD-Q)

Cognitive Failure Questionnaire (CFQ)

biomarkers

Cognitive Tests

Phase

NA

Detailed Description:

The SCD-Q is a well-established screening instrument to quantify perceived subjective cognitive decline. In addition to self-perceived cognitive complaints, a 24-item questionnaire for informants is part of the SCD-Q. It demonstrates high sensitivity and lower specificity for detecting dementia and early cognitive changes associated with dementia. However, the questionnaire has not been translated into German or validated. Plasma biomarkers for amyloid and tau pathology, as well as for neurodegeneration and astrocytic activation, have been developed and show promising sensitivity and specificity for detecting Alzheimer's disease (AD). A relevant proportion of biomarker-positive patients does not convert to mild cognitive impairment or Alzheimer's disease dementia during the disease course. Currently, the predictive value of blood biomarkers remains to be clarified, particularly in conjunction with SCD. This study aims to validate the SCD-Q in German and analyze possible connections with biomarkers and (digital) cognitive tests. Follow-up visits are planned.

Study Type : INTERVENTIONAL
Estimated Enrollment : 300 participants
Masking : NONE
Primary Purpose : SCREENING
Official Title : German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q) and Its Potential Use in Large Cohorts
Actual Study Start Date : 2023-02-01
Estimated Primary Completion Date : 2025-08-31
Estimated Study Completion Date : 2025-08-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 50 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * Medical appointment for dementia diagnostics at the Alzheimer Therapie- und Forschungszentrum
  • * Provision of signed, written and dated informed consent
  • * Capacity to give informed consent
Exclusion Criteria
  • * dementia in a very advance stage
  • * Illiteracy

German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

Location Details

NCT06711952


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

Germany, Bavaria

Clinic and polyclinic for psychiatry and psychotherapy at the LMU Clinic

München, Bavaria, Germany, 80336

Loading...